Combination of a TNF-alpha antagonist and a VEGF antagonist for use in the treatment or prevention of diseases of the eye.

Details for Australian Patent Application No. 2010251966 (hide)

Owner Glaxo Group Limited

Inventors Adamson, Peter; Ertl, Peter Franz; Germaschewski, Volker; Gough, Gerald Wayne; Steward, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010251966

PCT Pub. Number WO2010/136492

Priority 61/181,887 28.05.09 US

Filing date 26 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/136492 Priority application(s): WO2010/136492

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251967-Substituted aminopropionic derivatives as neprilysin inhibitors

2010251961-Albumin-amyloid peptide conjugates and uses thereof